All Comments by Albrecht Stöffler
- Antidepressant Citalopram Shows Promise as Future Anti-Amyloid Agent
- Bapineuzumab Phase 3: Target Engagement, But No Benefit
- Q&A With Ryan Watts, Genentech Lead Scientist on API Trial
- Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele.
- Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study.